U.S. hands Novavax $1.6b to work on COVID-19 vaccine

Name: U.S. hands Novavax $1.6b to work on COVID-19 vaccine
Uploaded: 2020-07-07T16:35:13+00:00
Duration: P132S
Description: The U.S. government awarded $1.6 billion to help Novavax quickly come up with a potential novel coronavirus vaccine, sending the stock surging more than 30

Credit: Reuters Studio

Duration: 02:12s 07 Jul 2020 0 shares 1 views

U.S. hands Novavax $1.6b to work on COVID-19 vaccine

The U.S. government awarded $1.6 billion to help Novavax quickly come up with a potential novel coronavirus vaccine, sending the stock surging more than 30 percent.

Conway G.

Gittens has more.

U.S. hands Novavax $1.6b to work on COVID-19 vaccine

You might like